ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

New Design For NCI’s CancerNet Wins Prestigious Web Site Design Awards.

November 17, 2000

AACR’s Elion Award Invites Applicants

December 10, 1993

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998

Hammer’s “March Of dollars” Starts Collecting Money; Four Year Campaign Kicks Off Oct 12

September 2, 1988

CCIRC Reviews Two Existing, One Prospective Cooperative Group

March 4, 1977

NCI Launches ALCHEMIST

September 5, 2014